A recent phase 3b long-term extension study assessed the safety and efficacy of deucravacitinib over 2 years in patients with moderate-to-severe plaque psoriasis.
Researchers evaluated the association between two surgical excision approaches and overall survival for patients with pathologically confirmed, localized, early-stage Merkel cell carcinoma.
Despite being approved for use, consensus among the real-world data on the use of IL-23 inhibitors in psoriatic disease has been lacking; therefore, researchers recently examined the drug survival and...
In a retrospective cohort study, researchers investigated the treatment patterns for adults in the United States with alopecia areata from 2015 to 2020.
To better understand the potential benefits of secukinumab use in patients with psoriatic arthritis, researchers examined the proportion of patients being treated with secukinumab that achieved low disease...
In a recent study presented at the American Academy of Dermatology’s annual meeting, researchers examined the efficacy of various doses of an oral JAK1/JAK2 inhibitor for treating patients with...
Researchers evaluated the efficacy of Janus kinase inhibitors in adult patients with alopecia areata. Their research was presented at the American Academy of Dermatology’s 2023 annual meeting in New...
In a recent study presented at the American Academy of Dermatology’s 2023 annual meeting, researchers examined the relationship between scalp hair loss severity and baseline distribution of eyebrow and...
